Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Merck

Making the Case for Covered Call Strategies

During times of uncertainty, an investor can use a covered call to deliver downside protection while capturing upside gains. Here’s how it works.

Kiplinger

Vaccines using mRNA can protect farm animals against diseases traditional ones may not – and there are safeguards to ensure they won't end up in your food

While effective vaccines for COVID-19 should have heralded the benefits of mRNA vaccines, fear and misinformation about their supposed dangers circulated at the same time. These misconceptions about mRNA vaccines have recently spilled over into worries about whether their use in agricultural animals could expose people to components of the…

The Conversation

Generate Income With A Cash-Secured Put On Merck Stock

A trader selling the July 21, 115-strike put could generate around $300 in premium per contract.

Investors Business Daily

From analysis to the latest developments in health,
read the most diverse news in one place.

Dow Jones Closes Lower While Uber Rockets. Carl Icahn Hits Back As Stock Craters On Short-Seller Attack.

The Dow Jones plunged as the latest Fed meeting kicked off. Carl Icahn hit back after Icahn Enterprises stock got slammed. Uber stock soared.

Investors Business Daily

Could Government Drug-Price Negotiations Sound The Death Knell For Biotech Stocks?

Industry analysts warn that a groundbreaking change in how Medicare buys drugs threatens industry growth, profits — and maybe patient care.

Investors Business Daily

Dow Jones Rises After Surprise Fall In Jobless Claims. Meta Surges, But This Hot AI Stock Crashes 30%.

The Dow Jones rose Thursday after a surprise drop in jobless claims. Meta stock surged, but hot AI stock Mobileye crashed 30% on earnings.

Investors Business Daily

Merck Reverses Higher As Keytruda, Gardasil Outplay Covid Decline; Bristol Shares Dip

Merck topped forecasts Thursday while Bristol Myers delivered a mixed performance. Merck stock swung to a gain while and BMY stock fell.

Investors Business Daily

Read news from The Economist, FT, and more,
with one subscription

Dow Jones Futures Rise: Meta Soars, Drug Giants Climb, Specialty Chip Plays Dive

Futures: Meta Platforms boomed on earnings, but megacap techs can't hide broad market rally weakness. First Republic dived again.

Investors Business Daily

Stock Market Rally Drifts Lower; Tesla Dives On Margins; ISRG, DHI, LVS Are Winners: Weekly Review

The major indexes saw modest declines, holding in a range. Tesla sold off as gross margins plunged. ISRG and DHI were earnings winners.

Investors Business Daily

1 Pharma Stock You'll Regret Not Buying Earlier

The long-term prospects of Merck (MRK) look bright due to its latest acquisitions and solid drug pipeline. Therefore, investing in this stock could help generate substantial returns in the long run. Keep reading….

StockNews.com

Stocks Close Mildly Higher on Q1 Earnings Optimism

What you need to know… The S&P 500 Index ($SPX ) (SPY ) Monday closed up +0.33%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +0.30%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.06%. Stock indexes Monday posted moderate gains. An increase in...

Barchart

Stocks Undercut by Higher Bond Yields and Weakness in Chip Stocks

What you need to know… The S&P 500 Index ($SPX ) (SPY ) today is up +0.05%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.11%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -0.23%. U.S. stock indexes this morning are mixed. An increase...

Barchart

Moderna Crumbles As Cancer Vaccine Data Show A 'Longish And Complex' Road

Moderna stock crumbled Monday after updated results for its Merck-partnered cancer vaccine show a "longish and complex path" toward approval.

Investors Business Daily

Stock Market Slides After Mixed Bank Earnings, Meta Downgrade, Google's AI Trauma

Google parent Alphabet sold off more than 3% after Samsung considered ditching the search engine.

Investors Business Daily

Get all your
news in one place.

100’s of premium titles.
One news app.

Investors Business Daily

Merck Nabs Prometheus Bio For $10.8 Billion As Keytruda Patent Expirations Loom

Merck is acquiring Prometheus Bio in a well-timed $10.8 billion deal ahead of Keytruda's patent loss. The news sent RXDX stock flying Monday.

Barchart

Markets Today: Stock Index Futures Mixed on Pressure from Higher Bond Yields

Morning Markets June S&P 500 futures (ESM2 3) this morning are up +0.02%, and June Nasdaq 100 E-Mini futures (NQM2 3) are down -0.03%. U.S. stock index futures this morning are mixed. An increase in M&A activity is positive for stocks after Merck said it would acquire Prometheus Biosciences for...

Tribune News Service

Study: Vaccine helps drug keep melanoma patients cancer-free

Adding a personalized cancer vaccine to the blockbuster drug Keytruda kept more melanoma patients in remission than the immune therapy alone, co-developers Moderna Inc. and Merck & Co. said in their first detailed presentation of a key study.

Investors Business Daily

Moderna Stock Yo-Yoes Winning A Key Battle For Its Cancer Vaccine

Moderna stock rose Monday after European regulators granted its Merck-partnered personalized cancer vaccine a key designation.

Get all your
news in one place.

100’s of premium titles.
One news app.

Investors Business Daily

5 S&P 500 Stocks Near Buy Points As Recession Fears Rise

Medical stocks are holding up amid economic and market uncertainty.

Investors Business Daily

Merck Stock Today: How A Bear Call Spread Can Return 10% In Less Than One Month

The maximum loss will occur if MRK closes above 115 on April 21.

The Guardian - UK

Does the future of medicine lie in space?

Earth’s gravity makes it harder to cultivate the proteins needed to study diseases and pathogens. And although the cost of space travel is high, private enterprise is stepping in

Foreign Policy

Insurance Agencies Would Love to Know Who Blew Up Nord Stream

An era of gray zone warfare and sabotage creates tough financial questions.

Bangkok Post

Pfizer buys biotech firm Seagen for $43 billion

WASHINGTON - US pharmaceutical giant Pfizer announced Monday that it had reached a deal to buy biotech firm Seagen, specializing in innovative cancer treatment, for $43 billion.

Investors Business Daily

Dow Jones Holds Above 32,000 As Index Bounce Fades; Financials Rocked Again As Regulators Shut Down SVB Financial

The Dow Jones climbed off lows Friday, but sellers regained control amid more broad-based selling in the financial sector.

Investors Business Daily

Could Merck's Next Keytruda-Like Franchise Generate $10 Billion In Sales?

Two of Merck's new drugs could generate north of $10 billion in peak sales, an analyst said Tuesday.

1 … 10 11 12 13

People

Elon Musk

23,067 stories

Dipanjan BanchurSince

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations